PFE vs WFC: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Wells Fargo & Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
VS
Wells Fargo & Company Β· Financial Services
$86.12
+20.4% upside to fair value
Med Conviction Grade B
QuantHub Verdict
WFC has more upside to fair value (+20.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PFE WFC
Current Price $27.64 $86.12
Fair Value Estimate $30.94 $103.68
Upside to Fair Value +12.0% +20.4%
Market Cap $157.5B $260.4B
Forward P/E β€” β€”
EV / EBITDA 17.4x 15.6x
Price / Sales 2.5x 2.0x
Price / FCF 14.3x 13.7x
Revenue Growth YoY +2.6% +11.3%
Gross Margin 71.3% 64.5%
Operating Margin 25.1% 21.2%
Return on Equity 4.9% 12.6%
Dividend Yield 6.22% 2.15%
FCF Yield 6.97% 7.3%
Analyst Consensus Hold Hold
Investment Thesis
PFE β€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
WFC β€” Wells Fargo & Company
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
Metric PFE WFC
Zone Low $23.21 $77.76
Zone High $26.30 $88.13
In Buy Zone? No Yes
← PFE Research    WFC Research β†’    All Research